BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 19562709)

  • 1. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D; Castillo E; Kumer S; Abouljoud M; Divine G; Pelletier S
    Transplant Proc; 2009; 41(1):216-8. PubMed ID: 19249517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY; Bass NM; Ascher NL; Roberts JP
    Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
    Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation.
    Khettry U; Azabdaftari G; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
    Liver Transpl; 2006 Jun; 12(6):958-65. PubMed ID: 16598742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant.
    Min AD; Saxena R; Thung SN; Atillasoy EO; Wolf DC; Sauter B; Schwartz ME; Bodenheimer HC
    Am J Gastroenterol; 1998 Nov; 93(11):2148-53. PubMed ID: 9820388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.